Liraglutide-A Novel GLP-1 Analogue

E-ISSN： 2212-3334|3|3|200-204

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.3, Iss.3, 2009-11, pp. : 200-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

GLP - 1 Analogs: Newer Molecules, Newer Uses

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 2, 2009-06 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 3, 2007-11 ,pp. : 193-201

Bentham Science Publishers

Access to resources Recommend Favorite

Incretins Yesterday, Pleiotropic Gastrointestinal Hormones Today:Glucagon-Like Peptide-1 (GLP-1) and Glucose-ependent Insulinotropic Polypeptide (GIP)

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 176-182

Bentham Science Publishers

Access to resources Recommend Favorite

Degludec: A Novel Basal Insulin

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 18-23

Bentham Science Publishers

Access to resources Recommend Favorite